Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

News Features

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

Michael O'Riordan

December 23, 2021

News Features

Cath Lab Teams Find Enduring Lessons in COVID-19’s Unending Reign

L.A. McKeown

December 20, 2021

News Features

As COVID-19 Drags on, the Cardiology Fallout May Haunt for Years

Caitlin E. Cox

December 16, 2021

News Features

World-wise: As In-Person Meetings Resume, Global Voices Hope to Be Heard

Shelley Wood

December 13, 2021

News Features

Home School: Clinical Trials Went Virtual in COVID-19—Are They Here to Stay?

Todd Neale

December 09, 2021

News Features

US Chest Pain Guidelines Will Change Practice, Though Gaps Remain

Yael L. Maxwell

December 06, 2021

News Features

Four Pillars, Fast? Rapid Sequencing of HF Drugs Faces an Uphill Battle

Shelley Wood

October 08, 2021

News Features

When the Time Comes to Stop Oral Anticoagulation: Options and Obstacles

Todd Neale

September 28, 2021

News Features

Expired Cardiac Devices May Do Global Good, but Safety Unknown

Yael L. Maxwell

August 26, 2021

News Features

Unseen and Unheard: In the Cath Lab, Anti-racism Efforts Fall Short

L.A. McKeown

June 18, 2021

News Features

Virtual Training Booms as COVID-19 Limits In-Person Proctoring, Observation

Yael L. Maxwell

April 21, 2021

News Features

Roughly 80% of ESC Guideline Writers Have Financial COIs

Michael O'Riordan

April 01, 2021

News Features

AI in Cardiology: Where We Are Now and Where to Go Next

Yael L. Maxwell

March 30, 2021

News Features

Crude Awakening: Should Interventional Cardiology Come Clean on Dirty Talk?

Shelley Wood

March 22, 2021

News Features

$45 Million OHSU Lawsuit Hits a Nerve for #CardiologyToo

Caitlin E. Cox

March 05, 2021

News Features

The Right Anticoagulation Dose in COVID-19? Final Answer Remains Elusive

Todd Neale

February 08, 2021

News Features

Cardiac Care Feels Staffing Crunch as Big Money Converts COVID-19 Travelers

Shelley Wood

January 20, 2021

News Features

Low Numbers and ‘Anecdata’: Shoddy Research Rode COVID-19’s First Wave

Michael O'Riordan

January 11, 2021

Advertisement

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

Cath Lab Teams Find Enduring Lessons in COVID-19’s Unending Reign

As COVID-19 Drags on, the Cardiology Fallout May Haunt for Years

World-wise: As In-Person Meetings Resume, Global Voices Hope to Be Heard

Home School: Clinical Trials Went Virtual in COVID-19—Are They Here to Stay?

US Chest Pain Guidelines Will Change Practice, Though Gaps Remain

Four Pillars, Fast? Rapid Sequencing of HF Drugs Faces an Uphill Battle

When the Time Comes to Stop Oral Anticoagulation: Options and Obstacles

Expired Cardiac Devices May Do Global Good, but Safety Unknown

Unseen and Unheard: In the Cath Lab, Anti-racism Efforts Fall Short

Virtual Training Booms as COVID-19 Limits In-Person Proctoring, Observation

Roughly 80% of ESC Guideline Writers Have Financial COIs

AI in Cardiology: Where We Are Now and Where to Go Next

Crude Awakening: Should Interventional Cardiology Come Clean on Dirty Talk?

$45 Million OHSU Lawsuit Hits a Nerve for #CardiologyToo

The Right Anticoagulation Dose in COVID-19? Final Answer Remains Elusive

Cardiac Care Feels Staffing Crunch as Big Money Converts COVID-19 Travelers

Low Numbers and ‘Anecdata’: Shoddy Research Rode COVID-19’s First Wave

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content